{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:31:14Z","timestamp":1785529874711,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":63,"publisher":"Springer US","isbn-type":[{"value":"9781071607701","type":"print"},{"value":"9781071607718","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0771-8_3","type":"book-chapter","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T07:02:49Z","timestamp":1598857369000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers"],"prefix":"10.1007","author":[{"given":"Rika","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"7","key":"3_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bies.200900112","volume":"32","author":"FF Costa","year":"2010","unstructured":"Costa FF (2010) Non-coding RNAs: meet thy masters. BioEssays 32(7):599\u2013608","journal-title":"BioEssays"},{"issue":"4","key":"3_CR2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli M-T, Viereck J et al (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96(4):1297\u20131325","journal-title":"Physiol Rev"},{"issue":"8","key":"3_CR3","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.3390\/ijms140816010","volume":"14","author":"AQ Gomes","year":"2013","unstructured":"Gomes AQ, Nolasco S, Soares H (2013) Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci 14(8):16010\u201316039","journal-title":"Int J Mol Sci"},{"issue":"25","key":"3_CR4","doi-asserted-by":"crossref","first-page":"37944","DOI":"10.18632\/oncotarget.9272","volume":"7","author":"P Krishnan","year":"2016","unstructured":"Krishnan P, Ghosh S, Graham K et al (2016) Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer. Oncotarget 7(25):37944","journal-title":"Oncotarget"},{"issue":"2","key":"3_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2012.07.033","volume":"48","author":"Q-F Yin","year":"2012","unstructured":"Yin Q-F, Yang L, Zhang Y et al (2012) Long noncoding RNAs with snoRNA ends. Mol Cell 48(2):219\u2013230","journal-title":"Mol Cell"},{"issue":"2","key":"3_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wrna.1324","volume":"7","author":"PY Ho","year":"2016","unstructured":"Ho PY, Yu AM (2016) Bioengineering of noncoding RNAs for research agents and therapeutics. Wiley Interdiscip Rev RNA 7(2):186\u2013197","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"12","key":"3_CR7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12):861","journal-title":"Nat Rev Genet"},{"issue":"12","key":"3_CR8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrm.2016.126","volume":"17","author":"JM Engreitz","year":"2016","unstructured":"Engreitz JM, Ollikainen N, Guttman M (2016) Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol 17(12):756","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10(3):155","journal-title":"Nat Rev Genet"},{"issue":"D1","key":"3_CR10","doi-asserted-by":"publisher","first-page":"D135","DOI":"10.1093\/nar\/gky1031","volume":"47","author":"PJ Volders","year":"2019","unstructured":"Volders PJ, Anckaert J, Verheggen K et al (2019) LNCipedia 5: towards a reference set of human long non-coding RNAs. Nucleic Acids Res 47(D1):D135\u2013D139. https:\/\/doi.org\/10.1093\/nar\/gky1031","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"3_CR11","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1093\/nar\/gks296","volume":"40","author":"VA Moran","year":"2012","unstructured":"Moran VA, Perera RJ, Khalil AM (2012) Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 40(14):6391\u20136400","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3_CR12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"L-L Chen","year":"2016","unstructured":"Chen L-L (2016) Linking long noncoding RNA localization and function. Trends Biochem Sci 41(9):761\u2013772","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"3_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13059-015-0586-4","volume":"16","author":"MN Cabili","year":"2015","unstructured":"Cabili MN, Dunagin MC, McClanahan PD et al (2015) Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol 16(1):20","journal-title":"Genome Biol"},{"issue":"1","key":"3_CR14","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/gb-2014-15-1-r6","volume":"15","author":"S van Heesch","year":"2014","unstructured":"van Heesch S, van Iterson M, Jacobi J et al (2014) Extensive localization of long noncoding RNAs to the cytosol and mono-and polyribosomal complexes. Genome Biol 15(1):R6","journal-title":"Genome Biol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.29245\/2572-9411\/2016\/3.1066","volume":"1","author":"KA Lennox","year":"2016","unstructured":"Lennox KA, Behlke MA (2016) Mini-review: current strategies to knockdown long non-coding RNAs. J Rare Dis Res Treat 1:66\u201370","journal-title":"J Rare Dis Res Treat"},{"issue":"2","key":"3_CR16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/nar\/gkv1206","volume":"44","author":"KA Lennox","year":"2015","unstructured":"Lennox KA, Behlke MA (2015) Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res 44(2):863\u2013877","journal-title":"Nucleic Acids Res"},{"issue":"7\u20138","key":"3_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00335-017-9686-7","volume":"28","author":"P Szafranski","year":"2017","unstructured":"Szafranski P, Karolak JA, Lanza D et al (2017) CRISPR\/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region. Mamm Genome 28(7\u20138):275\u2013282","journal-title":"Mamm Genome"},{"issue":"1","key":"3_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15476286.2017.1391443","volume":"15","author":"J Yang","year":"2018","unstructured":"Yang J, Meng X, Pan J et al (2018) CRISPR\/Cas9-mediated noncoding RNA editing in human cancers. RNA Biol 15(1):35\u201343","journal-title":"RNA Biol"},{"issue":"1","key":"3_CR19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1186\/s12864-015-2086-z","volume":"16","author":"E Aparicio-Prat","year":"2015","unstructured":"Aparicio-Prat E, Arnan C, Sala I et al (2015) DECKO: single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics 16(1):846","journal-title":"BMC Genomics"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4939-1862-1_13","volume-title":"Chromosomal mutagenesis","author":"T Gutschner","year":"2015","unstructured":"Gutschner T (2015) Silencing long noncoding RNAs with genome-editing tools. In: Chromosomal mutagenesis. Springer, New York, pp 241\u2013250"},{"key":"3_CR21","first-page":"1","volume":"2","author":"P Koirala","year":"2016","unstructured":"Koirala P, Zou D-H, Mo Y-Y (2016) Long non-coding RNAs as key regulators of cancer metastasis. J Cancer Metastasis Treat 2:1\u201310","journal-title":"J Cancer Metastasis Treat"},{"issue":"6","key":"3_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/cbr.2018.2510","volume":"34","author":"M Salehi","year":"2019","unstructured":"Salehi M, Sharifi M, Bagheri M (2019) Knockdown of long noncoding RNA plasmacytoma variant translocation 1 with antisense locked nucleic acid GapmeRs exerts tumor-suppressive functions in human acute erythroleukemia cells through downregulation of C-MYC expression. Cancer Biother Radiopharm 34(6):371\u2013379","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"3_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-5793(87)80171-0","volume":"215","author":"H Inoue","year":"1987","unstructured":"Inoue H, Hayase Y, Iwai S et al (1987) Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett 215(2):327\u2013330. https:\/\/doi.org\/10.1016\/0014-5793(87)80171-0","journal-title":"FEBS Lett"},{"issue":"4","key":"3_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00063030-200721040-00004","volume":"21","author":"A Gr\u00dcnweiler","year":"2007","unstructured":"Gr\u00dcnweiler A, Hartmann RK (2007) Locked nucleic acid oligonucleotides. BioDrugs 21(4):235\u2013243","journal-title":"BioDrugs"},{"key":"3_CR25","volume-title":"Advances in nucleic acid therapeutics","author":"MJ Gait","year":"2019","unstructured":"Gait MJ, Agrawal S (2019) Advances in nucleic acid therapeutics, vol 68. Royal Society of Chemistry, London"},{"issue":"24","key":"3_CR26","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1073\/pnas.88.24.11535","volume":"88","author":"H Nakamura","year":"1991","unstructured":"Nakamura H, Oda Y, Iwai S et al (1991) How does RNase H recognize a DNA. RNA hybrid? Proc Natl Acad Sci U S A 88(24):11535\u201311539","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR27","volume":"1","author":"PP Seth","year":"2012","unstructured":"Seth PP, Jazayeri A, Yu J et al (2012) Structure activity relationships of \u03b1-L-LNA modified phosphorothioate gapmer antisense oligonucleotides in animals. Mol Ther Nucleic Acids 1:e47","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"3_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/hum.2015.070","volume":"26","author":"KE Lundin","year":"2015","unstructured":"Lundin KE, Gissberg O, Smith CI (2015) Oligonucleotide therapies: the past and the present. Hum Gene Ther 26(8):475\u2013485. https:\/\/doi.org\/10.1089\/hum.2015.070","journal-title":"Hum Gene Ther"},{"issue":"3","key":"3_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/jpm3030144","volume":"3","author":"JJ Lee","year":"2013","unstructured":"Lee JJ, Yokota T (2013) Antisense therapy in neurology. J Pers Med 3(3):144\u2013176. https:\/\/doi.org\/10.3390\/jpm3030144","journal-title":"J Pers Med"},{"issue":"3","key":"3_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR (2017) Non-coding RNAs as drug targets. Nat Rev Drug Discov 16(3):167","journal-title":"Nat Rev Drug Discov"},{"key":"3_CR31","volume-title":"Anticancer therapeutics","author":"H Khan","year":"2008","unstructured":"Khan H, Missailidis S (2008) Antisense Agents. In: Anticancer therapeutics, vol 317. Wiley, Chichester"},{"issue":"6","key":"3_CR32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","volume":"37","author":"W Shen","year":"2019","unstructured":"Shen W, De Hoyos CL, Migawa MT et al (2019) Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat Biotechnol 37(6):640\u2013650","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3_CR33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/genes10050363","volume":"10","author":"S Naessens","year":"2019","unstructured":"Naessens S, Ruysschaert L, Lefever S et al (2019) Antisense oligonucleotide-based downregulation of the G56R pathogenic variant causing NR2E3-associated autosomal dominant retinitis Pigmentosa. Genes 10(5):363","journal-title":"Genes"},{"issue":"12","key":"3_CR34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/gtc.12730","volume":"24","author":"T Yoshida","year":"2019","unstructured":"Yoshida T, Naito Y, Yasuhara H et al (2019) Evaluation of off-target effects of gapmer antisense oligonucleotides using human cells. Genes Cells 24(12):827\u2013835","journal-title":"Genes Cells"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-429-6_1","volume":"453","author":"NR Markham","year":"2008","unstructured":"Markham NR, Zuker M (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol 453:3\u201331. https:\/\/doi.org\/10.1007\/978-1-60327-429-6_1","journal-title":"Methods Mol Biol"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"W361","DOI":"10.1093\/nar\/gku406","volume":"42","author":"I Paz","year":"2014","unstructured":"Paz I, Kosti I, Ares M Jr et al (2014) RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res 42:W361\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gku406","journal-title":"Nucleic Acids Res"},{"key":"3_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.72","volume":"3","author":"L Pedersen","year":"2014","unstructured":"Pedersen L, Hagedorn PH, Lindholm MW et al (2014) A kinetic model explains why shorter and less affine enzyme-recruiting oligonucleotides can be more potent. Mol Ther Nucleic Acids 3:e149. https:\/\/doi.org\/10.1038\/mtna.2013.72","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"3_CR38","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1093\/nar\/gkg580","volume":"31","author":"N Tolstrup","year":"2003","unstructured":"Tolstrup N, Nielsen PS, Kolberg JG et al (2003) OligoDesign: optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling. Nucleic Acids Res 31(13):3758\u20133762","journal-title":"Nucleic Acids Res"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.omtn.2018.03.009","volume":"11","author":"PM Moreno","year":"2018","unstructured":"Moreno PM, Ferreira AR, Salvador D et al (2018) Hydrogel-assisted antisense LNA Gapmer delivery for in situ gene silencing in spinal cord injury. Mol Ther Nucleic Acids 11:393\u2013406","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"3_CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/genes8080207","volume":"8","author":"F Leti","year":"2017","unstructured":"Leti F, DiStefano J (2017) Long noncoding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes 8(8):207","journal-title":"Genes"},{"issue":"1","key":"3_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1349-7006.2010.01737.x","volume":"102","author":"S Chung","year":"2011","unstructured":"Chung S, Nakagawa H, Uemura M et al (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 102(1):245\u2013252","journal-title":"Cancer Sci"},{"issue":"19","key":"3_CR42","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1158\/1078-0432.CCR-06-2882","volume":"13","author":"Y Guan","year":"2007","unstructured":"Guan Y, Kuo W-L, Stilwell JL et al (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13(19):5745\u20135755","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3_CR43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","volume":"132","author":"K Panzitt","year":"2007","unstructured":"Panzitt K, Tschernatsch MM, Guelly C et al (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132(1):330\u2013342","journal-title":"Gastroenterology"},{"issue":"1","key":"3_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-4608(01)00634-3","volume":"133","author":"L Pibouin","year":"2002","unstructured":"Pibouin L, Villaudy J, Ferbus D et al (2002) Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 133(1):55\u201360","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"3_CR45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0306-4522(02)00942-9","volume":"117","author":"T Bussire","year":"2003","unstructured":"Bussire T, Gold G, Kvari E et al (2003) Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer\u2019s disease. Neuroscience 117(3):577\u2013592","journal-title":"Neuroscience"},{"issue":"6","key":"3_CR46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF00968788","volume":"17","author":"W Lukiw","year":"1992","unstructured":"Lukiw W, Handley P, Wong L et al (1992) BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 17(6):591\u2013597","journal-title":"Neurochem Res"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"34862","DOI":"10.1038\/srep34862","volume":"6","author":"M Nair","year":"2016","unstructured":"Nair M, Sagar V, Pilakka-Kanthikeel S (2016) Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection. Sci Rep 6:34862","journal-title":"Sci Rep"},{"issue":"1","key":"3_CR48","doi-asserted-by":"crossref","first-page":"e00596","DOI":"10.1128\/mBio.00596-12","volume":"4","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Chen C-Y, Yedavalli VS et al (2013) NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio 4(1):e00596\u2013e00512","journal-title":"MBio"},{"issue":"12","key":"3_CR49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10038-006-0070-9","volume":"51","author":"N Ishii","year":"2006","unstructured":"Ishii N, Ozaki K, Sato H et al (2006) Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 51(12):1087","journal-title":"J Hum Genet"},{"issue":"7","key":"3_CR50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00109-013-1028-y","volume":"91","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Diederichs S (2013) MALAT1\u2014a paradigm for long noncoding RNA function in cancer. J Mol Med 91(7):791\u2013801","journal-title":"J Mol Med"},{"issue":"10","key":"3_CR51","volume":"5","author":"J Liu","year":"2014","unstructured":"Liu J, Yao J, Li X et al (2014) Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5(10):e1506","journal-title":"Cell Death Dis"},{"issue":"3","key":"3_CR52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL (2018) Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med 24(3):257\u2013277","journal-title":"Trends Mol Med"},{"issue":"9","key":"3_CR53","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, Stamato MA, Juli G et al (2018) Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia 32(9):1948","journal-title":"Leukemia"},{"key":"3_CR54","volume-title":"Non-coding RNAs as key players for understanding oncogenic pathways in ovarian cancer: studying new therapeutic strategies","author":"AS Castillo","year":"2019","unstructured":"Castillo AS, Mateos CO, Riera MS et al (2019) Non-coding RNAs as key players for understanding oncogenic pathways in ovarian cancer: studying new therapeutic strategies. AACR, Philadelphia"},{"issue":"8","key":"3_CR55","doi-asserted-by":"crossref","first-page":"E1509","DOI":"10.1073\/pnas.1616521114","volume":"114","author":"CJ Woo","year":"2017","unstructured":"Woo CJ, Maier VK, Davey R et al (2017) Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Proc Natl Acad Sci U S A 114(8):E1509\u2013E1518","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8651-4_4","volume-title":"Exon skipping and inclusion therapies","author":"K Goodkey","year":"2018","unstructured":"Goodkey K, Aslesh T, Maruyama R et al (2018) Nusinersen in the treatment of spinal muscular atrophy. In: Exon skipping and inclusion therapies. Springer, New York, pp 69\u201376"},{"issue":"326","key":"3_CR57","doi-asserted-by":"crossref","first-page":"326ra322","DOI":"10.1126\/scitranslmed.aaf1475","volume":"8","author":"J Viereck","year":"2016","unstructured":"Viereck J, Kumarswamy R, Foinquinos A et al (2016) Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med 8(326):326ra322","journal-title":"Sci Transl Med"},{"issue":"2","key":"3_CR58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.201812-2313ED","volume":"200","author":"D Jiang","year":"2019","unstructured":"Jiang D, Liang J (2019) A lncRNA Links TGF-\u03b2 Signaling in Lung Fibrosis. Am J Respir Crit Care Med 200(2):123\u2013125","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"3_CR59","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.1613203114","volume":"114","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y, Nakamura A, Nagata T et al (2017) Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 114(16):4213\u20134218. https:\/\/doi.org\/10.1073\/pnas.1613203114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci U S A 102(1):198\u2013203. https:\/\/doi.org\/10.1073\/pnas.0406700102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3_CR61","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1021\/acs.nanolett.5b00490","volume":"15","author":"K Ezzat","year":"2015","unstructured":"Ezzat K, Aoki Y, Koo T et al (2015) Self-assembly into nanoparticles is essential for receptor mediated uptake of therapeutic antisense oligonucleotides. Nano Lett 15(7):4364\u20134373. https:\/\/doi.org\/10.1021\/acs.nanolett.5b00490","journal-title":"Nano Lett"},{"issue":"10","key":"3_CR62","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1023\/A:1016260110049","volume":"12","author":"I Walker","year":"1995","unstructured":"Walker I, Irwin WJ, Akhtar S (1995) Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates. Pharm Res 12(10):1548\u20131553","journal-title":"Pharm Res"},{"key":"3_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.76","volume":"4","author":"Y Echigoya","year":"2015","unstructured":"Echigoya Y, Aoki Y, Miskew B et al (2015) Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice. Mol Ther Nucleic Acids 4:e225. https:\/\/doi.org\/10.1038\/mtna.2014.76","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Methods in Molecular Biology","Gapmers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0771-8_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:49:32Z","timestamp":1696603772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0771-8_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071607701","9781071607718"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0771-8_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}